In this special, live edition of the pharmaphorum podcast, recorded at the conclusion of Frontiers Health 2022, pharmaphorum Editor in Chief Jonah Comstock and pharmaphoru
As the Frontiers Health 2022 conference in Milan on 20th to 21st October draws ever nearer, pharmaphorum has been catching up with members of the event’s Steering Committee to find out more
Healthcare agency, consultancy and digital health group, Healthware, has announced the acquisition of Finland-based digital service development and creative agency Make Helsinki.
Chinese biotech Hutchmed has completed its rolling marketing application in the US for oral VEGF receptor inhibitor fruquintinib, which was licensed by Takeda for a hefty
